When Titan/Braeburn do trials on other doses, I see the the FDA following CVS's lead and pulling all forms of buprenorphine that can be abused (including the generics) from the market. Titan/Braeburn will be the be the next RB and have a monopoly in the market, which will be over $2 billion then.
I think your the only person that is getting the point. Cvs's Pbm not covering suboxone has nothing to do with any benefits, side effects from the drug. If you have two products that are essentially the same and one is losing/lost its patent your going to quit making the one that is going off patent and try to move people to your branded product. Now if your the guy paying for all this which are you paying for the generic or the brand. Cvs will still pay for generic tabs they just aren't paying for the brand film.